ACON · Aclarion Inc
United States · RS rating 7 · As of 2026-10-14
| Price | 1.94 USD |
|---|---|
| 1-day change | -9.3% |
| RS rating (overall / 1M / 3M / 12M) | 7 / 8 / 14 / 6 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 26 / 14 / 41 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +16.4% |
| Sales growth Q/Q | -2.4% |
| Distance from 52-week high | +78.7% |
| Market cap (USD) | $7.4M |